Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Cancer|February 2, 2019
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2James K Godfrey, Chadi Nabhan, Theodore Karrison, et al.
Annals of Translational Medicine|June 24, 2024
FLT3 inhibitor maintenance after allogeneic stem cell transplantation in FLT3-mutated acute myeloid leukemia (AML) patientsGong He, Erika Belmont, Theodore Karrison, et al.
The Journal of Applied Laboratory Medicine|October 23, 2019
Analytical Differences in Intraoperative Parathyroid Hormone AssaysEdward K Y Leung, Christine C Lee, Peter Angelos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortiumSonali M Smith, Koen van Besien, Theodore Karrison, et al.
Cancer Research|April 19, 2005
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiationErik T Kimchi, Mitchell C Posner, James O Park, et al.
Breast Cancer Research and Treatment|November 23, 2024
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltrationMargarite D Matossian, Christine Shiang, Deniz Nesli Dolcen, et al.
Environment International|December 8, 2017
Pregnancy outcomes and ethanol cook stove intervention: A randomized-controlled trial in Ibadan, NigeriaDonee A Alexander, Amanda Northcross, Theodore Karrison, et al.
Cancer|May 5, 2020
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO studyTanguy Y Seiwert, Sara Kochanny, Kevin Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
A phase I trial to determine the safety, tolerability, and maximum tolerated dose of deforolimus in patients with advanced malignanciesChristine M Hartford, Apurva A Desai, Linda Janisch, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2006
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis StudyRima McLeod, Kenneth Boyer, Theodore Karrison, et al.
Pageof 15